Drug Trial Radar · NCT01370356
A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction
Last checked: Nov 19, 2026Latest source record: Sep 1, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,510
Actual
Start
Jul 2011
Primary completion
Jul 2013
Study completion Jul 2013
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jun 9, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Health services research
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will determine whether varenicline is safe and helps people to quit smoking through reduction when they are not willing/able to make an abrupt quit attempt.
Conditions
- Smoking Cessation
Interventions
Varenicline TartrateDrug
Varenicline Tartrate oral tablets 2 (0.5mg) tablets twice a day for 24 weeks (first week titration)
PlaceboDrug
Matching placebo 2 oral tablets twice a day for 24 weeks (first week titration)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Carbon Monoxide (CO) Confirmed 10-Week Continuous Abstinence (CA) From SmokingTime frame: Week 15 - 24
Locations
65 sites in 10 countries. Site status is shown where the registry gives one.
Pharmacology Research Institute
Encino, California
Pharmacology Research Institute
Newport Beach, California
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Central Kentucky Research Associates, Inc.
Lexington, Kentucky
Mayo Clinic
Rochester, Minnesota
The Center for Pharmaceutical Research, P.C.
Kansas City, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
CRI Worldwide, LLC
Marlton, New Jersey
Clinical Research Integrity(CRI) Worldwide, LLC
Willingboro, New Jersey
Central New York Clinical Research
Manlius, New York
FutureSearch Clinical Trials, L.P.
Austin, Texas
Benchmark Research
Fort Worth, Texas
Healthfirst Medical Group
Fort Worth, Texas
Australian Clinical Research Network
Maroubra, New South Wales, Australia
Brisbane South Clinical Research Centre
Carina Heights, Queensland, Australia
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia
Emeritus Research
Malvern, Victoria, Australia
Office of Dr. Ronald Collette
Burnaby, British Columbia, Canada
James K. Lai, MD., Inc.
Vancouver, British Columbia, Canada
White Hills Medical Clinic
St. John's, Newfoundland and Labrador, Canada
Canadian Phase Onward Inc.
Toronto, Ontario, Canada
Manna Research
Toronto, Ontario, Canada
Clinique des Maladies Lipidiques de Quebec (CMLQ)
Québec, Quebec, Canada
SurGal Clinic s.r.o.
Brno, Czechia
Fakultni nemocnice u sv. Anny v Brne
Brno, Czechia
Krajska nemocnice Liberec a.s., Plicni oddeleni
Liberec, Czechia
Mestska nemocnice Ostrava, Plicni oddeleni
Ostrava, Czechia
Vseobecna fakultni nemocnice v Praze, III. interni klinika
Prague, Czechia
Vseobecna fakultni nemocnice v Praze
Prague, Czechia
Ustredni vojenska nemocnice Praha
Prague, Czechia
Alexandria University
Alexandria, Egypt
Ain Shams University Hospital
Cairo, Egypt
El Fayoum university hospital
El Fayoum Qesm, Egypt
Klinische Forschung Berlin
Berlin, Germany
Klinische Forschung Berlin-Buch GmbH
Berlin, Germany
Universitaetsklinikum Goettingen Zentrum Innere Medizin Abteilung Kardiologie und Pneumologie
Göttingen, Germany
Universitaetsklinikum Goettingen, Zentrum Innere Medizin, Abteilung Kardiologie und Pneumologie
Göttingen, Germany
Klinische Forschung Hamburg GmbH
Hamburg, Germany
Medamed- Studienambulanz
Leipzig, Germany
Showing 40 of 65 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.